Bone marrow transplantation, commonly known as hematopoietic stem cell transplantation (HSCT), has undergone technological advancements in recent years. We will discuss how technological advances, such as improved stem cell extraction procedures, have enabled PBSC transplantation. Haploidentical transplantation is useful when finding a perfectly matched donor is difficult since it broadens the pool of potential donors.
About Bone Marrow Transplantation
Bone marrow transplantation is used to treat leukemia, lymphoma, multiple myeloma, aplastic anemia, and thalassemia. Bone marrow diseases have a major impact on patients. Technology has improved and made significant advances in bone marrow transplantation, increasing patient outcomes. Indian bone marrow transplant candidates must be aware of these developments in order to make informed judgments. There are two types of bone marrow, each having a particular purpose.
The importance of bone marrow transplantation and accompanying technologies has grown as stem cell harvesting techniques have been refined. Stem cell transplants make use of bone marrow. Technology has made peripheral blood stem cell (PBSC) transplantation possible. PBSC transplantation has outperformed traditional stem cell collection protocols in many countries, including India. Haploidentical transplantation is one of several advances in bone marrow transplantation. This stem cell transplant involves distantly matched donors and recipients. This increases the number of potential donors, which is beneficial when locating a fully matched donor is difficult. Following successful clinical trials, India now provides haploidentical transplants for blood malignancies.
"Conditioning regimens," which involve pre-transplant chemotherapy and radiation therapies to prepare the recipient's immune system to accept donor stem cells, have also increased success rates. More patients, particularly the elderly and those with various medical conditions, are receiving transplants thanks to less hazardous reduced-intensity conditioning (RIC) regimens. This has increased bone marrow transplants in India.
Infection prevention and control have also led to better transplant outcomes. Understanding graft-versus-host disease (GVHD), a major side effect of bone marrow transplantation, has resulted in better prevention and therapy.
Next-generation sequencing has enhanced the diagnosis and monitoring of MRD, which is the small number of cancer cells that may remain following treatment. MRD monitoring enhances bone marrow transplant outcomes by allowing for more accurate therapy response evaluation and treatment planning.
Advancements in Bone Marrow Transplantation in India
Patients with certain types of blood cancers, hematological disorders, or other conditions that affect the various types of bone marrow may benefit from advances in bone marrow transplantation, also known as hematopoietic stem cell transplantation (HSCT), which involves transplanting healthy donor stem cells into the patient. Bone marrow transplantation in India has advanced significantly in recent years, resulting in improved patient outcomes and the prospect of transplantation for a broader spectrum of illnesses.
New and improved methods: High-resolution human leukocyte antigen (HLA) typing is one example of how India has evolved in bone marrow transplantation; this method is utilized to identify the patient's ideal donor match. The outcome has been increased transplant success rates and fewer complications.
Increased capacity of donor database: The National Bone Marrow Donor register (NMDP India), part of the larger National Marrow Donor Programme (NMDP) network, has greatly expanded India's donor register for bone marrow transplants. As a result, there are more possible donors for patients who require a bone marrow transplant.
Transplantation of cord blood: Cord blood transplantation, a type of HSCT that uses stem cells derived from umbilical cord blood, has gained popularity in India. Donated cord blood is extracted from umbilical cords after delivery and stored in banks for future use. This has created a new potential source of stem cells for transplantation for patients who do not have a matched donor in their family or on a donor registry.
Conditioning program with reduced strength of effort: In India, bone marrow transplants are increasingly being performed with reduced intensity conditioning (RIC) regimens, which use fewer doses of chemotherapy and radiation than traditional high-dose conditioning regimens. Older patients and those with comorbidities respond better to RIC regimens, increasing their transplant eligibility and improving their prognosis.
Taking a multidisciplinary approach: Hematologists, oncologists, transplant surgeons, radiologists, and supportive care providers are just a few of the professions that collaborate to do bone marrow transplants in India. Working together, specialty centers now provide comprehensive therapy for patients undergoing bone marrow transplantation, increasing patient care and outcomes.
Science and creativity: In India, bone marrow transplants are performed by a multidisciplinary team that includes hematologists, oncologists, transplant surgeons, radiologists, and supportive care specialists. Working together, specialty centers may now provide comprehensive therapy for patients having bone marrow transplantation, which improves patient care and results.
Cost-effectiveness: Although bone marrow transplantation is an expensive procedure, there have been recent initiatives in India to minimize the cost to patients. Certain hospitals and institutes have offered reduced or discounted prices for bone marrow transplantation in order to make it more accessible to a larger variety of patients.
Conclusion
To summarize, India has made considerable progress and breakthroughs in bone marrow transplantation by enhancing donor registries, cord blood transplantation, conditioning regimens, multidisciplinary approaches, research, and costs. These advances in bone marrow transplantation have made it a more viable therapeutic choice for blood malignancies, hematological illnesses, and other bone marrow diseases, as well as increased the number of people eligible for transplants. In recent years, India's bone marrow transplant research and innovation have provided patients hope and enhanced treatment options.
Dr. Satyendra Katewa, Director & Head of Department
Blood & Marrow Transplant and Cellular Therapies
Book an Appointment
Find a Doctor 
Send a Query
Book an Appointment
Second Opinion